$TXG Cashflow Statement | Understand Stock

$TXG

$72.96 +$1.41 (1.97%) Close

$TXG Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities:
Net loss
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Stock-based compensation expense
Loss on disposal of property and equipment
Loss on extinguishment of debt
Amortization of premium and accretion of discount on marketable securities, net
Depreciation and amortization
Asset and lease impairment charges
ROU assets impairment due to restructuring
Amortization of right-of-use assets
Class A common stock issued for in-process research and development
Accretion of discount on term loan
Fair value adjustments on contingent consideration
Realized loss on marketable securities
Other
Changes in operating assets and liabilities:
Accounts receivable
Other receivables
Inventory
Prepaid expenses and other current assets
Other noncurrent assets
Accounts payable
Accrued compensation and other related benefits
Deferred revenue
Accrued contingent liabilities
Accrued expenses and other current liabilities
Deferred rent, noncurrent
Operating lease liability
Other noncurrent liabilities

Net cash provided by (used in) operating activities
Investing activities:
Proceeds from maturities of marketable securities
Proceeds from sales of marketable securities
Purchase of marketable securities
Asset acquisition, net
Purchases of property and equipment
Purchase of intangible assets
Acquisition of business, net of cash acquired
Net cash (used in) provided by investing activities
Financing activities:
Payments on term loans
Proceeds from borrowings under revolver
Payments on borrowings under revolver
Issuance of common stock from exercise of stock options and employee stock purchase plan purchases
Payments on technology license financing arrangement
Proceeds from issuance of common stock upon initial and follow-on public offerings, net of issuance costs
Net cash provided by financing activities

Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash, cash equivalents and restricted cash at beginning of year
Cash and cash equivalents at end of year
Supplemental disclosures of cash flow information:
Cash paid for interest
Cash paid for taxes
Noncash investing and financing activities
Purchases of property and equipment included in accounts payable, accrued expenses and other current liabilities
Right-of-use assets obtained in exchange for new operating lease liabilities
Conversion of convertible preferred stock into common stock upon initial public offering
Purchase of technology licenses under financing arrangement
Contingent consideration payable related to business acquisition
Common stock issued for acquisition of assets

Comments